182 related articles for article (PubMed ID: 16612597)
1. Effects of interferon gamma on native human acute myelogenous leukaemia cells.
Ersvaer E; Skavland J; Ulvestad E; Gjertsen BT; Bruserud Ø
Cancer Immunol Immunother; 2007 Jan; 56(1):13-24. PubMed ID: 16612597
[TBL] [Abstract][Full Text] [Related]
2. T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-gamma that can be further increased by a novel protein kinase C agonist PEP005.
Ersvaer E; Hampson P; Hatfield K; Ulvestad E; Wendelbo Ø; Lord JM; Gjertsen BT; Bruserud Ø
Cancer Immunol Immunother; 2007 Jun; 56(6):913-25. PubMed ID: 17115221
[TBL] [Abstract][Full Text] [Related]
3. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax.
Lisovsky M; Estrov Z; Zhang X; Consoli U; Sanchez-Williams G; Snell V; Munker R; Goodacre A; Savchenko V; Andreeff M
Blood; 1996 Nov; 88(10):3987-97. PubMed ID: 8916965
[TBL] [Abstract][Full Text] [Related]
4. T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC).
Olsnes AM; Motorin D; Ryningen A; Zaritskey AY; Bruserud Ø
Cancer Immunol Immunother; 2006 Jul; 55(7):830-40. PubMed ID: 16267679
[TBL] [Abstract][Full Text] [Related]
5. In vitro effects of R-verapamil on the cytokine environment and T-lymphocyte proliferation when human T-lymphocyte activation takes place in the presence of acute myelogenous leukemia blasts.
Bruserud O
Cancer Chemother Pharmacol; 1996; 39(1-2):71-8. PubMed ID: 8995502
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8.
Zhou M; Zhang Y; Ardans JA; Wahl LM
J Biol Chem; 2003 Nov; 278(46):45406-13. PubMed ID: 12960156
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation of proteins in primary human myeloid leukemia cells stimulated by cytokines: analysis of the frequency of phosphorylation, and partial identification and semi-quantification of signaling molecules.
Hagiwara S; Iki S; Urabe A; Saeki K; Miwa A; Togawa A; Ozawa K; Takaku F; Yuo A
Int J Hematol; 1998 Dec; 68(4):387-401. PubMed ID: 9885438
[TBL] [Abstract][Full Text] [Related]
8. Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells.
Bruserud Ø; Ryningen A; Olsnes AM; Stordrange L; Øyan AM; Kalland KH; Gjertsen BT
Haematologica; 2007 Mar; 92(3):332-41. PubMed ID: 17339182
[TBL] [Abstract][Full Text] [Related]
9. Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia; characterization of the cytokine repertoire of clonogenic T cells.
Bruserud O
Cancer Immunol Immunother; 1998 Jun; 46(4):221-8. PubMed ID: 9671145
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
[TBL] [Abstract][Full Text] [Related]
11. Cross-inhibition of interferon-induced signals by GM-CSF through a block in Stat1 activation.
Kasper S; Kindler T; Sonnenschein S; Breitenbuecher F; Böhmer FD; Huber C; Fischer T
J Interferon Cytokine Res; 2007 Nov; 27(11):947-59. PubMed ID: 18052729
[TBL] [Abstract][Full Text] [Related]
12. In vitro induction of a dendritic cell phenotype in primary human acute myelogenous leukemia (AML) blasts alters the chemokine release profile and increases the levels of T cell chemotactic CCL17 and CCL22.
Olsnes AM; Ryningen A; Ersvaer E; Bruserud Ø
J Interferon Cytokine Res; 2008 May; 28(5):297-310. PubMed ID: 18547160
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts.
Foss B; Ulvestad E; Bruserud Ø
Eur J Haematol; 2001 Oct; 67(4):267-78. PubMed ID: 11860452
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of native human acute myelogenous leukemia blasts on fibroblasts and osteoblasts.
Glenjen N; Ersvaer E; Ryningen A; Bruserud Ø
Int J Cancer; 2004 Oct; 111(6):858-67. PubMed ID: 15300797
[TBL] [Abstract][Full Text] [Related]
15. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-13 secretion by normal and posttransplant T lymphocytes; in vitro studies of cellular immune responses in the presence of acute leukaemia blast cells.
Bruserud O; Pawelec G
Cancer Immunol Immunother; 1997 Oct; 45(1):45-52. PubMed ID: 9353426
[TBL] [Abstract][Full Text] [Related]
17. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia.
Biethahn S; Alves F; Wilde S; Hiddemann W; Spiekermann K
Exp Hematol; 1999 May; 27(5):885-94. PubMed ID: 10340405
[TBL] [Abstract][Full Text] [Related]
18. Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.
Corbera-Bellalta M; Planas-Rigol E; Lozano E; Terrades-García N; Alba MA; Prieto-González S; García-Martínez A; Albero R; Enjuanes A; Espígol-Frigolé G; Hernández-Rodríguez J; Roux-Lombard P; Ferlin WG; Dayer JM; Kosco-Vilbois MH; Cid MC
Ann Rheum Dis; 2016 Jun; 75(6):1177-86. PubMed ID: 26698852
[TBL] [Abstract][Full Text] [Related]
19. Impact of CXCR4 inhibition on FLT3-ITD-positive human AML blasts.
Jacobi A; Thieme S; Lehmann R; Ugarte F; Malech HL; Koch S; Thiede C; Müller K; Bornhäuser M; Ryser M; Brenner S
Exp Hematol; 2010 Mar; 38(3):180-90. PubMed ID: 20035824
[TBL] [Abstract][Full Text] [Related]
20. p91 STAT1 activation in interleukin-3-stimulated primary acute myeloid leukemia cells.
Aronica MG; Brizzi MF; Dentelli P; Rosso A; Yarden Y; Pegoraro L
Oncogene; 1996 Sep; 13(5):1017-26. PubMed ID: 8806691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
